MYL5 and breast carcinoma: The results showed that in Kaplan–Meier plotter and PrognoScan databases, the OS, DMFS, RFS, and PPS of breast cancer patients were significantly prolonged in the MYL5 high-expression group, compared with the MYL5 low-expression group.